(a) For purposes of this section:
(1) “Opioid antagonist” shall have the meaning set forth in section 17a-714a.
(2) “Prescribing practitioner” shall have the meaning set forth in section 20-14c.
(3) “Pharmacist” shall have the meaning set forth in section 20-609a.
(b) A prescribing practitioner or a pharmacist certified to prescribe naloxone pursuant to section 20-633c may enter into an agreement with a law enforcement agency, emergency medical service provider, government agency, community health organization or local or regional board of education related to the distribution and administration of an opioid antagonist for the reversal of an opioid overdose. The prescribing practitioner or pharmacist shall provide training to persons who will distribute or administer the opioid antagonist pursuant to the terms of the agreement. Persons other than the prescribing practitioner or pharmacist shall receive training in the distribution or administration of opioid antagonists prior to distributing or administering an opioid antagonist. The agreement shall address the storage, handling, labeling, recalls and recordkeeping of opioid antagonists by the law enforcement agency, emergency medical service provider, government agency, community health organization or local or regional board of education which is party to the agreement.
(c) A prescribing practitioner or pharmacist who enters into an agreement pursuant to subsection (b) of this section shall not be liable for damages in a civil action or subject to administrative or criminal prosecution for the administration or dispensing of an opioid antagonist by such law enforcement agency, emergency medical service provider, government agency, community health organization or local or regional board of education.
(d) The Commissioner of Consumer Protection may adopt regulations, in accordance with the provisions of chapter 54, to implement the provisions of this section.
(P.A. 18-166, S. 3; P.A. 22-80, S. 8.)
History: P.A. 18-166 effective July 1, 2018; P.A. 22-80 amended Subsecs. (b) and (c) by adding “or local or regional board of education” and making conforming changes, effective July 1, 2022.
Structure Connecticut General Statutes
Title 21a - Consumer Protection
Chapter 420b - Dependency-Producing Drugs
Section 21a-240. (Formerly Sec. 19-443). - Definitions.
Section 21a-241. (Formerly Sec. 19-449). - Prior regulations continued.
Section 21a-242. (Formerly Sec. 19-450a). - Schedules of controlled substances. Exceptions.
Section 21a-243. (Formerly Sec. 19-451). - Regulations. Schedules of controlled substances.
Section 21a-247. (Formerly Sec. 19-454). - Qualifications of applicant for license.
Section 21a-249. (Formerly Sec. 19-457). - Prescription requirements.
Section 21a-250. (Formerly Sec. 19-458). - Rights and duties of pharmacist.
Section 21a-253. - Possession of marijuana pursuant to a prescription.
Section 21a-254a. - Appointment of prescription drug monitoring working group. Membership.
Section 21a-258. (Formerly Sec. 19-465). - Exceptions concerning possession and control.
Section 21a-264. (Formerly Sec. 19-470). - Notice to licensing boards of violations by licensees.
Section 21a-266. (Formerly Sec. 19-472). - Prohibited acts.
Section 21a-272. (Formerly Sec. 19-475). - Preparations which may be sold and dispensed. Exceptions.
Section 21a-273. (Formerly Sec. 19-476). - Substances exempt under federal law.
Section 21a-274. (Formerly Sec. 19-477). - Cooperation in enforcement of law.
Section 21a-275. (Formerly Sec. 19-478). - Revocation or suspension of licenses by commissioner.
Section 21a-276. (Formerly Sec. 19-479). - Discretion of commissioner to issue warning.
Section 21a-279d. - Cannabis given by one consumer to another.
Section 21a-280. (Formerly Sec. 19-481a). - Breathing of anesthesia not violation.
Section 21a-282. (Formerly Sec. 19-482). - No prosecution where federal action has been taken.
Section 21a-283a. - Court authorized to depart from imposing mandatory minimum sentence.
Section 21a-307. (Formerly Sec. 19-504i). - Definitions re dispensing of drugs.